ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 197 filers reported holding ANI PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $680,754 | +7.7% | 11,725 | -0.1% | 0.12% | +12.7% |
Q2 2023 | $631,964 | +42.3% | 11,740 | +5.0% | 0.11% | +41.0% |
Q1 2023 | $444,109 | -65.6% | 11,181 | -69.6% | 0.08% | -45.1% |
Q2 2021 | $1,290,000 | +124.7% | 36,818 | +295.3% | 0.14% | +73.2% |
Q4 2020 | $574,000 | +121.6% | 9,315 | +46.4% | 0.08% | +60.8% |
Q1 2020 | $259,000 | -62.1% | 6,361 | -42.6% | 0.05% | -44.6% |
Q4 2019 | $683,000 | -16.1% | 11,075 | -0.9% | 0.09% | -20.0% |
Q3 2019 | $814,000 | -60.1% | 11,175 | -54.9% | 0.12% | -57.2% |
Q2 2019 | $2,039,000 | +4.0% | 24,805 | -10.7% | 0.27% | -0.7% |
Q1 2019 | $1,960,000 | +50.3% | 27,780 | -4.1% | 0.27% | +34.2% |
Q4 2018 | $1,304,000 | -22.5% | 28,955 | -2.7% | 0.20% | -8.2% |
Q3 2018 | $1,683,000 | +0.5% | 29,760 | +18.7% | 0.22% | -8.3% |
Q2 2018 | $1,675,000 | +11.1% | 25,075 | -3.2% | 0.24% | +11.6% |
Q1 2018 | $1,508,000 | +108.0% | 25,900 | +130.2% | 0.22% | +117.2% |
Q4 2017 | $725,000 | – | 11,250 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |